Gengraf 25 mg/1

Gengraf 25 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by AbbVie Inc. in the USA.

Gengraf 25 mg capsules are primarily used to prevent the body from rejecting transplanted organs. This medication works by suppressing the immune system, which helps the body accept the new organ. It is often prescribed for patients who have undergone kidney, liver, or heart transplants. The active ingredient, cyclosporine, is a potent immunosuppressant that plays a crucial role in transplant surgery recovery.

Common effects of Gengraf 25 mg capsules may include headaches, tremors, and increased hair growth. Some users might experience gastrointestinal issues such as nausea or diarrhea. It is important to monitor for any signs of infection or unusual bleeding, as these could indicate a serious reaction.

Gengraf 25 mg capsules should be handled with care, especially regarding dosage and administration. It is crucial to follow the prescribed regimen to avoid complications. Patients should avoid grapefruit and grapefruit juice, as they can interfere with the medication's effectiveness. Regular blood tests may be required to monitor kidney function and drug levels.

Gengraf 25 mg capsules can interact with a variety of medications, including certain antibiotics, antifungals, and heart medications. Alcohol should be avoided, as it can increase the risk of side effects. Patients should inform their healthcare provider about all medications they are taking to prevent potential interactions.